mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.08 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.09 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.092 |
0.09 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.057 |
0.09 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.088 |
0.09 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |